Italian COPD patient registry study
Treatments studied
Part of Heart & circulation, Infections, Lungs & breathing clinical trials.
This study is creating a registry to better understand Chronic Obstructive Pulmonary Disease (COPD) in Italian patients. It will collect information from people with COPD to improve care and research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 40 years old
- You have smoked 20 pack-years or less in your lifetime (that means up to one pack a day for 20 years, or two packs a day for 10 years, etc.)
- Your lung function test shows a specific pattern called COPD, with a ratio of FEV1 (how much air you can forcefully exhale in one second) to VC (total slow exhalation) below the normal limit
- You do not currently have significant asthma
- You do not have other major lung diseases like interstitial lung disease (scarring of the lung tissue) or bronchiectasis (widened airways that trap mucus)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks the health of people with COPD who are receiving their usual treatments. It helps doctors learn more about how the disease affects people over time and aims to improve care.
This study looks at how COPD affects your breathing and heart health. It is for people who are newly diagnosed with COPD and have a history of smoking.
This observational study collects information on people with COPD (chronic lung disease) who have a severe flare requiring ICU care. It does not test a new drug, but the data may help doctors better understand severe COPD episodes and ICU outcomes.
This study looks at the link between heart or blood vessel disease and lung conditions like COPD or severe asthma. It aims to better understand and improve care for people with these conditions.
This study follows people with COPD over time to better understand their lung health and how it changes. It may help researchers and doctors learn what factors affect breathing and long-term outcomes.
This study collects information from people with severe asthma across Italy to better understand the condition and improve treatment. By joining, you help researchers learn what works best for people like you.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.